Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.

Cancer Prevention Research
D G EvansA Howell

Abstract

The aim of this study is to determine breast cancer risk at mammographic screening episodes and integrate standard risk factors with mammographic density and genetic data to assess changing the screening interval based on risk and offer women at high risk preventive strategies. We report our experience of assessing breast cancer risk within the U.K. National Health Service Breast Screening Program using results from the first 10,000 women entered into the "Predicting Risk Of breast Cancer At Screening" study. Of the first 28,849 women attending for screening at fifteen sites in Manchester 10,000 (35%) consented to study entry and completed the questionnaire. The median 10-year Tyrer-Cuzick breast cancer risk was 2.65% (interquartile range, 2.10-3.45). A total of 107 women (1.07%) had 10-year risks 8% or higher (high breast cancer risk), with a further 8.20% having moderately increased risk (5%-8%). Mammographic density (percent dense area) was 60% or more in 8.3% of women. We collected saliva samples from 478 women for genetic analysis and will extend this to 18% of participants. At time of consent to the study, 95.0% of women indicated they wished to know their risk. Women with a 10-year risk of 8% or more or 5% to 8% and mamm...Continue Reading

References

Apr 16, 1997·Journal of the National Cancer Institute·J S PankowT A Sellers
Sep 24, 1999·Journal of the National Cancer Institute·J P CostantinoH S Wieand
Jul 6, 2000·Journal of the National Cancer Institute·M T MandelsonE White
Sep 20, 2002·The New England Journal of Medicine·Norman F BoydJohn L Hopper
Oct 9, 2002·Journal of Medical Screening·K McCafferyW Atkin
Jan 22, 2004·British Journal of Cancer·S CiattoM Zappa
Apr 2, 2004·Statistics in Medicine·Jonathan TyrerJack Cuzick
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 7, 2006·Journal of the National Cancer Institute·William E BarlowKarla Kerlikowske
Sep 7, 2006·Journal of the National Cancer Institute·Jinbo ChenMitchell H Gail
Feb 13, 2007·Clinical Radiology·G J R PorterJ Chakrabarti
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jul 20, 2007·Endocrine-related Cancer·Richard J SantenUNKNOWN Breast Cancer Prevention Collaborative Group
Jun 27, 2008·The New England Journal of Medicine·Paul D P PharoahBruce A J Ponder
Jul 25, 2008·Breast Cancer Research : BCR·Stephen W DuffyFiona J Gilbert
Nov 15, 2008·BMJ : British Medical Journal·Usha MenonIan Jacobs
Jun 19, 2009·Journal of the National Cancer Institute·Mitchell H Gail
Jan 8, 2010·Journal of Medical Screening·Maureen G C GillanStephen W Duffy
Mar 23, 2010·Breast Cancer Research and Treatment·Christian R LoehbergPeter A Fasching
Apr 30, 2010·Journal of the National Cancer Institute·Eitan AmirD Gareth Evans
May 11, 2010·Nature Genetics·Clare TurnbullDouglas F Easton
Oct 20, 2010·Journal of the National Cancer Institute·Matthew E MealiffeDavid A Hinds

❮ Previous
Next ❯

Citations

May 4, 2013·Lancet·Jack CuzickUNKNOWN SERM Chemoprevention of Breast Cancer Overview Group
Feb 16, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Susmita ChowdhuryHilary Burton
Jun 8, 2013·Journal of the National Cancer Institute·Jeffrey A TiceKarla Kerlikowske
Jan 25, 2013·Radiology Research and Practice·Ana Laura Calderón-GarcidueñasRicardo M Cerda-Flores
Nov 30, 2013·Breast Cancer Research : BCR·Suzanne A EcclesAlastair M Thompson
Dec 15, 2012·Breast Cancer Research and Treatment·Sebastien AntoniValerie McCormack
Dec 10, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S G SmithJ Cuzick
Dec 4, 2014·Breast Cancer Research : BCR·Anthony HowellMichelle N Harvie
Oct 17, 2013·Journal of Internal Medicine·N PashayanH Burton
May 16, 2013·Statistics in Medicine·Matthew SperrinIain Buchan
Mar 30, 2016·British Journal of Cancer·D Gareth R EvansAnthony Howell
Jul 15, 2015·Breast Cancer Research : BCR·D Gareth Evans, Anthony Howell
Jul 15, 2015·International Journal of Breast Cancer·Wenda HeReyer Zwiggelaar
Feb 25, 2015·The Breast : Official Journal of the European Society of Mastology·Susanne F MeiselJane Wardle
Jul 28, 2016·Psycho-oncology·Andrea GibbonsJenny Groarke
Apr 7, 2018·Journal of Medical Imaging and Radiation Oncology·Jennifer Stone
Feb 16, 2018·Climacteric : the Journal of the International Menopause Society·K E McLean, J Stone
Feb 15, 2017·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Juliet A Usher-SmithJoanne Warcaba
Feb 7, 2018·Breast Cancer Research : BCR·Susan M AstleyD Gareth Evans
Feb 18, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Young Ae KimJae Hun Jung
Sep 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Ki-Bong YooEun-Cheol Park
Jul 19, 2017·Molecular Genetics & Genomic Medicine·Alison Johnston, Michael Sugrue
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Ayla Acikgoz, Gul Ergor
May 8, 2018·British Journal of Cancer·David P FrenchLouise S Donnelly
Aug 22, 2013·Cancer Prevention Research·Christina R WeisstockChristine Wilson
Apr 1, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Nov 29, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·D Gareth R EvansFiona Lalloo
Nov 4, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anthony HowellD Gareth Evans
Nov 13, 2019·Reproductive Toxicology·Nickilou Y KrigbaumBarbara A Cohn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.